Results 51 to 60 of about 6,851,925 (312)

Oncogenes asociados al cáncer oral

open access: yesGaceta Médica Estudiantil, 2023
Introducción: la Organización Mundial de la Salud acoge al termino cáncer como “Un amplio grupo de enfermedades que pueden afectar a cualquier parte del cuerpo; también se habla de «tumores malignos» o «neoplasias”.
Gabriela Liseth Vaca-Altamirano   +2 more
doaj  

Efficacy evaluation of an oral powder supplement enriched with eicosapentaenoic acid in cancer patients [PDF]

open access: yes, 2011
Introducción: El efecto beneficioso del ácido eicosapentaenoico en pacientes con cáncer está ampliamente descrito sobre todo en lo que respecta a su rol en la caquexia tumoral. Objetivo: Evaluar la eficacia de la administración de un nuevo suplemento
Bermejo, Laura María   +5 more
core   +2 more sources

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

Lesiones precancerosas y cáncer oral: Aspectos clínicos [PDF]

open access: yes, 2010
Existen múltiples lesiones precancerosas en la cavidad oral, sin embargo la más frecuente es la leucoplasia. Hay una forma con especial tendencia a la degeneración maligna, la leucoplasia verrugosa proliferativa.
Bagán Sebastián, José Vicente
core  

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Prevalencia y caracterización del cáncer laríngeo en pacientes atendidos en el Servicio de Otorrinolaringología del Hospital Antonio Lenín Fonseca en el período comprendido 2013 al 2015 [PDF]

open access: yes, 2016
El cáncer de laringe representa un 20% - 25% de los carcinomas de cabeza y cuello. El consumo de tabaco y alcohol son los factores epidemiológicos más comunes en el cáncer de cavidad oral, orofaringe, hipofaringe, y laringe.
Morales Arancibia, Anielka Eunice
core  

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

open access: yesMolecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern   +7 more
wiley   +1 more source

Research progress on induced autophagy for the treatment of oral cancer

open access: yes口腔疾病防治, 2023
Oral cancer has a high degree of malignancy, easily recurs, readily metastasizes and poor progonsis. Autophagy is a catabolic process induced in cells under stressful conditions.
CHEN Weimin, GUO Jincai , XIE Hui
doaj   +1 more source

Expresión de cambios histopatológicos adaptativos y/o neoplásicos en el hígado de ratones CF-1 expuestos a la ingesta crónica de 4-nitroquinolina-1-oxido [PDF]

open access: yes, 2010
69 p.INTRODUCCIÓN: El cáncer de hígado es la tercera causa de muerte relacionada con cáncer en el mundo y constituye el 6% de los nuevos cánceres diagnosticados.
Venegas Rojas, Bernardo (Prof. Guía)   +1 more
core  

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy